Key statistics
On Friday, Cytosorbents Corp (HQE1:STU) closed at 1.25, -33.08% below its 52-week high of 1.87, set on Sep 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.21 |
---|---|
High | 1.25 |
Low | 1.21 |
Bid | 1.31 |
Offer | 1.41 |
Previous close | 1.21 |
Average volume | 0.00 |
---|---|
Shares outstanding | 54.43m |
Free float | 52.34m |
P/E (TTM) | -- |
Market cap | 84.37m USD |
EPS (TTM) | -0.526 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
- CytoSorbents Secures $20 Million Credit Facility
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
More ▼